New approaches to moderate CRISPR-Cas9 activity: Addressing issues of cellular uptake and endosomal escape
Open Access
- 1 January 2022
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 30 (1) , 32-46
Abstract
No abstract availableKeywords
Funding Information
- Danmarks Tekniske Universitet
This publication has 134 references indexed in Scilit:
- DNA targeting specificity of RNA-guided Cas9 nucleasesNature Biotechnology, 2013
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cellsNature Biotechnology, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Multiplex Genome Engineering Using CRISPR/Cas SystemsScience, 2013
- Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteriaProceedings of the National Academy of Sciences, 2012
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial ImmunityScience, 2012
- Pharmacological Modulation of Humoral Immunity in a Nonhuman Primate Model of AAV Gene Transfer for Hemophilia BMolecular Therapy, 2012
- Targeted minicircle DNA delivery using folate–poly(ethylene glycol)–polyethylenimine as non-viral carrierBiomaterials, 2010
- Proton Sponge Trick for pH-Sensitive Disassembly of Polyethylenimine-Based siRNA Delivery SystemsBioconjugate Chemistry, 2010
- Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytesProceedings of the National Academy of Sciences, 2007